Mycotopia Therapies, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
AIBOTICS, Inc. CEO Benjamin Kaplan acquired 75 million shares of common stock at $0.003 per share as payment for accrued salary, increasing his beneficial ownership to 95.25 million shares.
Mycotopia Therapies director, Mark Croskery, acquired 10 million shares of common stock in lieu of cash compensation for director's fees.
Mycotopia Therapies CEO, Benjamin Kaplan, acquired 20 million shares of common stock in lieu of cash compensation for director's fees.